Cargando…

Safety and acceptability of clozapine and risperidone in progressive multiple sclerosis: a phase I, randomised, blinded, placebo-controlled trial

OBJECTIVE: Because clozapine and risperidone have been shown to reduce neuroinflammation in humans and mice, the Clozapine and Risperidone in Progressive Multiple Sclerosis (CRISP) trial was conducted to determine whether clozapine and risperidone are suitable for progressive multiple sclerosis (pMS...

Descripción completa

Detalles Bibliográficos
Autores principales:	La Flamme, Anne C, Abernethy, David, Sim, Dalice, Goode, Liz, Lockhart, Michelle, Bourke, David, Milner, Imogen, Garrill, Toni-Marie, Joshi, Purwa, Watson, Eloise, Smyth, Duncan, Lance, Sean, Connor, Bronwen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7903182/ https://www.ncbi.nlm.nih.gov/pubmed/33681788 http://dx.doi.org/10.1136/bmjno-2020-000060

Ejemplares similares

RISPERIDONE AUGMENTATION OF CLOZAPINE
por: Agarwal, Vivek
Publicado: (1999)

Amelioration of experimental autoimmune encephalomyelitis by clozapine is not associated with defective CD4 T cell responses
por: Zareie, Pirooz, et al.
Publicado: (2017)

Clozapine reduces infiltration into the CNS by targeting migration in experimental autoimmune encephalomyelitis
por: Robichon, Katharina, et al.
Publicado: (2020)

Treatment with the Antipsychotic Agent, Risperidone, Reduces Disease Severity in Experimental Autoimmune Encephalomyelitis
por: O'Sullivan, David, et al.
Publicado: (2014)

Clozapine administration enhanced functional recovery after cuprizone demyelination
por: Templeton, Nikki, et al.
Publicado: (2019)

Metabolic profiles differences of overweight patients on olanzapine, clozapine and risperidone
por: Liew, Siew Fai, et al.
Publicado: (2021)

Metabolic profiles differences of overweight patients on olanzapine, clozapine and risperidone
por: Liew, Siew Fai, et al.
Publicado: (2021)

Clozapine and risperidone influence on cortisol and estradiol levels in male patients with schizophrenia
por: Piriu, G, et al.
Publicado: (2015)

Akathisia rate among psychiatric patients treated with Clozapine compared to Risperidone.
por: Stryjer, R., et al.
Publicado: (2023)

Localisation of clozapine during experimental autoimmune encephalomyelitis and its impact on dopamine and its receptors
por: Robichon, Katharina, et al.
Publicado: (2021)

Characteristics of the corpus callosum in chronic schizophrenia treated with clozapine or risperidone and those never-treated
por: Tao, Bo, et al.
Publicado: (2021)

Enhanced disease reduction using clozapine, an atypical antipsychotic agent, and glatiramer acetate combination therapy in experimental autoimmune encephalomyelitis
por: Green, Laura K, et al.
Publicado: (2017)

Clozapine, chlorpromazine and risperidone dose-dependently reduce emotional hyperthermia, a biological marker of salience
por: Blessing, William W., et al.
Publicado: (2017)

Evaluation of neurological changes in secondary progressive multiple sclerosis patients treated with immune modulator MIS416: results from a feasibility study
por: Webster, Gill A., et al.
Publicado: (2017)

Comparative study of clozapine versus risperidone in treatment-naive, first-episode schizophrenia: A pilot study
por: Sahni, Sukhtej, et al.
Publicado: (2016)

Characteristics of White Matter Structural Networks in Chronic Schizophrenia Treated With Clozapine or Risperidone and Those Never Treated
por: Luo, Chunyan, et al.
Publicado: (2020)

Comparative study of sexual dysfunction and serum prolactin level associated with olanzapine, risperidone, and clozapine in patients with remitted schizophrenia
por: Sathish Kumar, S. V., et al.
Publicado: (2015)

PM450. Effects of olanzapine, clozapine, risperidone and sertindole on FGF2, synapsin and NGF expression in the hippocampus of naive mice
por: Ulak, Guner, et al.
Publicado: (2016)

Negative Correlation between Serum S100B and Leptin Levels in Schizophrenic Patients During Treatment with Clozapine and Risperidone: Preliminary Evidence
por: Hendouei, Narjes, et al.
Publicado: (2016)

Acute Administration of Clozapine and Risperidone Altered Dopamine Metabolism More in Rat Caudate than in Nucleus Accumbens: A Dose-Response Relationship
por: Batool, Farhat, et al.
Publicado: (2010)

Two cases of life‐threatening arrhythmia induced by risperidone: evaluation of risperidone and 9‐hydroxy‐risperidone concentrations
por: Ito, Asami, et al.
Publicado: (2017)

Evaluation of the effectiveness and acceptability of intramuscular clozapine injection: illustrative case series
por: Henry, Rebecca, et al.
Publicado: (2020)

Association between polymorphisms of LEP, LEPR, DRD2, HTR2A and HTR2C genes and risperidone- or clozapine-induced hyperglycemia
por: Puangpetch, Apichaya, et al.
Publicado: (2019)

RISPERIDONE IN SCHIZOPHRENIA
por: Agashe, Mohan, et al.
Publicado: (1999)

RISPERIDONE IN SCHIZOPHRENIA
por: Kumar, P.N. Suresh
Publicado: (1999)

Prevalence of treatment resistance and clozapine use in early intervention services
por: Stokes, Imogen, et al.
Publicado: (2020)

Co-administration of 5-HT6 receptor antagonists with clozapine, risperidone, and a 5-HT2A receptor antagonist: effects on prepulse inhibition in rats
por: Fijał, Katarzyna, et al.
Publicado: (2013)

Galactorrhea Induced by Risperidone
por: Sakaguchi, Shota, et al.
Publicado: (2019)

Audit on prolactin monitoring for patients on oral risperidone, intramuscular risperidone, and intramuscular paliperidone
por: Bader, Mohamed
Publicado: (2021)

The Steady-State Comparative Bioavailability of Intramuscular Risperidone ISM and Oral Risperidone: An Open-Label, One-Sequence Study
por: Walling, David P, et al.
Publicado: (2021)

Why has adolescent smoking declined dramatically? Trend analysis using repeat cross-sectional data from New Zealand 2002–2015
por: Ball, Jude, et al.
Publicado: (2018)

New Zealand radiation therapists’ perceptions of peer group supervision as a tool to reduce burnout symptoms in the clinical setting
por: Dungey, Gay, et al.
Publicado: (2020)

The DREADD agonist clozapine N-oxide (CNO) is reverse-metabolized to clozapine and produces clozapine-like interoceptive stimulus effects in rats and mice
por: Manvich, Daniel F., et al.
Publicado: (2018)

DELUSIONAL PARASITOSIS RESPONDING TO RISPERIDONE
por: Gowda, B.S.Narayana, et al.
Publicado: (2002)

Risperidone in the treatment of bipolar mania
por: Sajatovic, Martha, et al.
Publicado: (2006)

RISPERIDONE-INDUCED OCULOGYRIC CRISIS
por: Khalid, Abdul, et al.
Publicado: (2000)

RISPERIDONE IN INDIAN PATIENTS WITH SCHIZOPHRENIA
por: Duggal, Harpreet S., et al.
Publicado: (1999)

Interaction between escitalopram and risperidone
por: Rao, Pradeep, et al.
Publicado: (2005)

RISPERIDONE IN INDIAN PATIENTS WITH SCHIZOPHRENIA
por: Agarwal, A.K., et al.
Publicado: (1998)

A Case of Priapism with Risperidone
por: Ginory, Almari, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_bit3nmkno44qrd8g9brk8pa582